← All trials
NCT06996730
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2026
- Primary completion
- Jun 1, 2030
- Completion date
- Jun 1, 2030
- First posted
- May 30, 2025
- Last posted
- Aug 3, 2025
- Enrollment
- 240
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ArizonaLead sponsor
- University of ArizonaOfficial
- Harvard UniversityOfficial
- Universidad de AntioquiaCollaborator
- National Institute on Aging (NIA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.